Article Information
History
- July 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Erick Gustavo Dorlassa,*,
- Karine Lima Lourençob,*,
- Rubens Daniel Miserani Magalhãesb,*,
- Hugo Satob,
- Alex Fiorinib,
- Renata Peixotob,
- Helena Perez Coelhob,
- Bruna Larotonda Telezynskia,
- Guilherme Pereira Scagiona,
- Tatiana Omettoa,
- Luciano Matsumiya Thomazellia,
- Danielle Bruna Leal Oliveirac,
- Ana Paula Fernandesb,
- Edison Luiz Durigona,
- Flavio Guimarães Fonsecab,# and
- Santuza Maria Ribeiro Teixeirab,#
- aUniversidade de São Paulo, São Paulo, São Paulo, Brazil
- bCentro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
- cHospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil
- ↵#Corresponding authors: S.M.R. Teixeira and F.G. Fonseca. Centro de Tecnologia de Vacinas - CTVacinas/UFMG. Rua Professor José Vieira de Mendonça, 770. Engenho Nogueira, Belo Horizonte - MG, Brazil. 31310-260; phone number: 55-31-34011226; email: santuzat{at}ufmg.br; fdafonseca{at}icb.ufmg.br
↵* These authors contributed equally to this work
Posted July 05, 2021.
Survey of SARS-CoV-2 genetic diversity in two major Brazilian cities using a fast and affordable Sanger sequencing strategy
